about
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for t...
Read More
6.86
-0.03
(-0.44%)
767.0K
XNAS Volume
XNAS 22 Jan, 2026 4:30 PM (EST)
High Financial Strength
Affordable Valuation
Technically Bullish
Strong Performer
These stock companies have strong financials and are affordably priced. They also score high in quality and technical metrics which make them popular with investors
View Similar
Embed DVM
Puma biotech Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..